Home Healthcare IT Liquid Handling Systems Market Size, Share and Forecast to 2031

Liquid Handling Systems Market Size, Share & Trends Analysis Report By Product (Systems, Consumables, Software), By Applications (Drug Discovery, Life Sciences, Diagnostics), By End-User (Diagnostic Companies, CMOs, CROs, Biopharmaceutical Companies, Research and Academic Institutions, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI54433DR
Last Updated : June 06, 2023
Author : Straits Research
Starting From
USD 2300
Buy Now

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Liquid Handling Systems Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Systems
        1. By Value
      3. Consumables
        1. By Value
      4. Software
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery
        1. By Value
      3. Life Sciences
        1. By Value
      4. Diagnostics
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Diagnostic Companies
        1. By Value
      3. CMOs
        1. By Value
      4. CROs
        1. By Value
      5. Biopharmaceutical Companies
        1. By Value
      6. Research and Academic Institutions
        1. By Value
      7. Others
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Systems
        1. By Value
      3. Consumables
        1. By Value
      4. Software
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery
        1. By Value
      3. Life Sciences
        1. By Value
      4. Diagnostics
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Diagnostic Companies
        1. By Value
      3. CMOs
        1. By Value
      4. CROs
        1. By Value
      5. Biopharmaceutical Companies
        1. By Value
      6. Research and Academic Institutions
        1. By Value
      7. Others
        1. By Value
    5. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Systems
          1. By Value
        3. Consumables
          1. By Value
        4. Software
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Drug Discovery
          1. By Value
        3. Life Sciences
          1. By Value
        4. Diagnostics
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Diagnostic Companies
          1. By Value
        3. CMOs
          1. By Value
        4. CROs
          1. By Value
        5. Biopharmaceutical Companies
          1. By Value
        6. Research and Academic Institutions
          1. By Value
        7. Others
          1. By Value
    6. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Systems
        1. By Value
      3. Consumables
        1. By Value
      4. Software
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery
        1. By Value
      3. Life Sciences
        1. By Value
      4. Diagnostics
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Diagnostic Companies
        1. By Value
      3. CMOs
        1. By Value
      4. CROs
        1. By Value
      5. Biopharmaceutical Companies
        1. By Value
      6. Research and Academic Institutions
        1. By Value
      7. Others
        1. By Value
    5. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Systems
          1. By Value
        3. Consumables
          1. By Value
        4. Software
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Drug Discovery
          1. By Value
        3. Life Sciences
          1. By Value
        4. Diagnostics
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Diagnostic Companies
          1. By Value
        3. CMOs
          1. By Value
        4. CROs
          1. By Value
        5. Biopharmaceutical Companies
          1. By Value
        6. Research and Academic Institutions
          1. By Value
        7. Others
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Systems
        1. By Value
      3. Consumables
        1. By Value
      4. Software
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery
        1. By Value
      3. Life Sciences
        1. By Value
      4. Diagnostics
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Diagnostic Companies
        1. By Value
      3. CMOs
        1. By Value
      4. CROs
        1. By Value
      5. Biopharmaceutical Companies
        1. By Value
      6. Research and Academic Institutions
        1. By Value
      7. Others
        1. By Value
    5. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Systems
          1. By Value
        3. Consumables
          1. By Value
        4. Software
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Drug Discovery
          1. By Value
        3. Life Sciences
          1. By Value
        4. Diagnostics
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Diagnostic Companies
          1. By Value
        3. CMOs
          1. By Value
        4. CROs
          1. By Value
        5. Biopharmaceutical Companies
          1. By Value
        6. Research and Academic Institutions
          1. By Value
        7. Others
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Systems
        1. By Value
      3. Consumables
        1. By Value
      4. Software
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery
        1. By Value
      3. Life Sciences
        1. By Value
      4. Diagnostics
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Diagnostic Companies
        1. By Value
      3. CMOs
        1. By Value
      4. CROs
        1. By Value
      5. Biopharmaceutical Companies
        1. By Value
      6. Research and Academic Institutions
        1. By Value
      7. Others
        1. By Value
    5. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Systems
          1. By Value
        3. Consumables
          1. By Value
        4. Software
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Drug Discovery
          1. By Value
        3. Life Sciences
          1. By Value
        4. Diagnostics
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Diagnostic Companies
          1. By Value
        3. CMOs
          1. By Value
        4. CROs
          1. By Value
        5. Biopharmaceutical Companies
          1. By Value
        6. Research and Academic Institutions
          1. By Value
        7. Others
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Systems
        1. By Value
      3. Consumables
        1. By Value
      4. Software
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Drug Discovery
        1. By Value
      3. Life Sciences
        1. By Value
      4. Diagnostics
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Diagnostic Companies
        1. By Value
      3. CMOs
        1. By Value
      4. CROs
        1. By Value
      5. Biopharmaceutical Companies
        1. By Value
      6. Research and Academic Institutions
        1. By Value
      7. Others
        1. By Value
    5. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Systems
          1. By Value
        3. Consumables
          1. By Value
        4. Software
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Drug Discovery
          1. By Value
        3. Life Sciences
          1. By Value
        4. Diagnostics
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Diagnostic Companies
          1. By Value
        3. CMOs
          1. By Value
        4. CROs
          1. By Value
        5. Biopharmaceutical Companies
          1. By Value
        6. Research and Academic Institutions
          1. By Value
        7. Others
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Liquid Handling Systems Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Danaher Corporation
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Agilent Technologies, Inc.
    3. Analytik Jena AG
    4. Beckman Coulter, Inc.
    5. Bio-Rad Laboratories, Inc.
    6. Eppendorf AG
    7. Tecan Group Ltd.
    8. Thermo Fisher Scientific Inc.
    9. Gardner Denver Medical
    10. Lonza AG
    11. Mettler-Toledo International Inc.
    12. Hamilton Company
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Liquid Handling System Market Size The market Size was valued at USD 4.59 Billion in 2024. It is projected to reach from USD 4.81 Billion by 2025 to USD 7.00 Billion by 2033, growing at a CAGR of 4.8% during the forecas
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :